Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
Christina M. Annunziata(National Cancer Institute), Louis M. Staudt(National Cancer Institute), Fenghuang Zhan(Winthrop Rockefeller Foundation), Lenny Dang(Millennium Engineering and Integration (United States)), Madhumita Santra(University of Arkansas for Medical Sciences), Owen Stephens(University of Arkansas for Medical Sciences), John D. Shaughnessy(University of Arkansas for Medical Sciences), Elaine M. Hurt, Georg Lenz(Charité - Universitätsmedizin Berlin), R. Eric Davis(The University of Texas MD Anderson Cancer Center), Hong Zhao(University of Washington), Ichiro Hanamura(University of Arkansas for Medical Sciences), Yulia N. Demchenko(National Cancer Institute), Bruce K. Tan(Northwestern University), Wenming Xiao(World Wide Web Consortium), George W. Wright(National Cancer Institute), W. Michael Kuehl(National Cancer Institute), Sandeep S. Davé(Duke University), Ana Gabrea(National Cancer Institute), William Bellamy(University of Arkansas for Medical Sciences), Bart Barlogie(University of Arkansas for Medical Sciences)
Cited by 949
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k